AKR1B10
Basic information
Region (hg38): 7:134527567-134541412
Previous symbols: [ "AKR1B11" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AKR1B10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 4 | 0 |
Variants in AKR1B10
This is a list of pathogenic ClinVar variants found in the AKR1B10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-134527969-A-C | not specified | Uncertain significance (Jan 04, 2022) | ||
7-134530802-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
7-134532005-A-G | not specified | Uncertain significance (Jan 18, 2023) | ||
7-134533043-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
7-134533062-C-T | not specified | Uncertain significance (May 11, 2022) | ||
7-134536651-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
7-134536708-G-A | not specified | Likely benign (Jan 17, 2023) | ||
7-134536718-G-T | not specified | Uncertain significance (Jun 23, 2021) | ||
7-134537586-G-A | Likely benign (Sep 01, 2022) | |||
7-134537589-A-T | Likely benign (Sep 01, 2022) | |||
7-134537592-A-G | Likely benign (Sep 01, 2022) | |||
7-134538204-G-A | not specified | Uncertain significance (Feb 26, 2024) | ||
7-134538210-A-G | not specified | Uncertain significance (Feb 10, 2022) | ||
7-134538230-G-T | not specified | Uncertain significance (Sep 16, 2021) | ||
7-134538241-G-C | not specified | Uncertain significance (Feb 14, 2024) | ||
7-134538255-C-A | not specified | Uncertain significance (Oct 06, 2022) | ||
7-134538276-A-G | not specified | Uncertain significance (Dec 28, 2023) | ||
7-134539007-A-G | not specified | Uncertain significance (Jul 06, 2021) | ||
7-134539016-C-G | not specified | Uncertain significance (Jul 06, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AKR1B10 | protein_coding | protein_coding | ENST00000359579 | 10 | 13817 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.57e-9 | 0.275 | 125537 | 3 | 201 | 125741 | 0.000812 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.193 | 180 | 173 | 1.04 | 0.00000893 | 2082 |
Missense in Polyphen | 61 | 58.305 | 1.0462 | 780 | ||
Synonymous | -0.932 | 77 | 67.3 | 1.14 | 0.00000384 | 573 |
Loss of Function | 0.620 | 14 | 16.7 | 0.836 | 7.06e-7 | 214 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00240 | 0.00240 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000511 | 0.000489 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000424 | 0.000422 |
Middle Eastern | 0.000511 | 0.000489 |
South Asian | 0.00297 | 0.00288 |
Other | 0.000818 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as all-trans-retinaldehyde reductase. Can efficiently reduce aliphatic and aromatic aldehydes, and is less active on hexoses (in vitro). May be responsible for detoxification of reactive aldehydes in the digested food before the nutrients are passed on to other organs. {ECO:0000269|PubMed:18087047}.;
- Pathway
- Folate biosynthesis - Homo sapiens (human);Fructose and mannose metabolism - Homo sapiens (human);Glycerolipid metabolism - Homo sapiens (human);Galactose metabolism - Homo sapiens (human);Pentose and glucuronate interconversions - Homo sapiens (human);Cyclophosphamide Pathway, Pharmacodynamics;Ifosfamide Pathway, Pharmacodynamics;Metapathway biotransformation Phase I and II;Signaling by GPCR;Signal Transduction;Metabolism of fat-soluble vitamins;acetone degradation I (to methylglyoxal);Glycine Serine metabolism;Metabolism;Metabolism of vitamins and cofactors;Retinoid metabolism and transport;G alpha (i) signalling events;Visual phototransduction;GPCR downstream signalling;methylglyoxal degradation III
(Consensus)
Recessive Scores
- pRec
- 0.320
Intolerance Scores
- loftool
- 0.904
- rvis_EVS
- 0.37
- rvis_percentile_EVS
- 75.43
Haploinsufficiency Scores
- pHI
- 0.154
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.916
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Akr1b8
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- retinoid metabolic process;farnesol catabolic process;daunorubicin metabolic process;doxorubicin metabolic process;oxidation-reduction process
- Cellular component
- extracellular region;mitochondrion;lysosome;cytosol
- Molecular function
- retinal dehydrogenase activity;alditol:NADP+ 1-oxidoreductase activity;aldo-keto reductase (NADP) activity;protein binding;alcohol dehydrogenase (NADP+) activity;oxidoreductase activity;geranylgeranyl reductase activity;indanol dehydrogenase activity